dr. herbst discusses challenges with immunotherapy in nsclc
Published 5 years ago • 52 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
1:00
dr. herbst discusses immunotherapy in lung cancer
-
1:20
dr. herbst discusses new immunotherapy agents for lung cancer
-
1:35
dr. herbst on promising immunotherapy combinations in nsclc
-
1:56
dr. herbst on advances of immunotherapy in lung cancer
-
2:29
dr. herbst discusses the state of immunotherapy in lung cancer
-
1:49
dr. herbst on the impact of frontline immunotherapy in lung cancer
-
1:59
dr. herbst on key immunotherapy findings in nsclc
-
0:58
dr. herbst on immunotherapy in lung cancer
-
1:35
dr. herbst on immuno-oncology combinations in lung cancer
-
1:14
dr. herbst on long term survival with pembrolizumab in nsclc
-
1:03
dr. herbst on combination therapies for lung cancer
-
1:22
dr. herbst on immune resistance in lung cancer
-
1:18
dr. herbst on next-generation agents in nsclc
-
1:42
dr. herbst on tmb as a biomarker in nsclc
-
1:02
dr. herbst on pd-1 inhibitors in lung cancer
-
1:44
dr. roy s. herbst discusses immunotherapy in squamous and nonsquamous nsclc
-
1:25
dr. brahmer on chemoimmunotherapy in patients with nsclc
-
1:23
dr. roy s. herbst explores molecular testing in lung cancer
-
2:15
dr. herbst on the next generation of lung cancer trials